Sarepta Therapeutics
A senior clinical development leader at Sarepta supporting late-stage genetic medicine programs across muscle, CNS, and cardiac diseases. The role reports to the Head of Clinical Development and contributes to advancing Sarepta’s gene therapy and broader therapeutic pipeline. Ideal candidates hold a doctorate (MD, PhD, or PharmD) and have extensive clinical and industry research experience.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Vice President, Late Stage Ophthalmology - DME
4D Molecular Therapeutics
Senior Director, Market Access Spain & Portugal
Cytokinetics
Senior Clinical Scientist
Alkeus Pharmaceuticals
Senior Director, Biostatistics
4D Molecular Therapeutics
Senior Director, Clinical Development Scientist, Pulmovant
Pulmovant
Head of Biostatistics
Zenas BioPharma